Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am, go to: https://goo.gl/O3l5KC use the password: freechatfriday

Prosensa Holding NV
(NASDAQ : RNA)

( )
RNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading RNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.28%155.001.1%$504.59m
GILDGilead Sciences, Inc.
-0.40%64.300.9%$489.93m
REGNRegeneron Pharmaceuticals, Inc.
0.00%455.702.7%$466.21m
CELGCelgene Corporation
0.00%116.741.1%$419.11m
BIIBBiogen Inc.
-0.06%252.811.2%$387.42m
ALXNAlexion Pharmaceuticals, Inc.
0.86%99.351.9%$353.97m
INCYIncyte Corporation
0.00%138.412.6%$272.84m
VRTXVertex Pharmaceuticals Incorporated
0.00%118.601.9%$199.99m
PBYIPuma Biotechnology, Inc.
-1.60%76.8021.1%$199.46m
ILMNIllumina, Inc.
0.00%173.763.5%$196.01m
EXASExact Sciences Corporation
0.00%33.1928.0%$151.08m
AAgilent Technologies, Inc.
0.00%59.311.5%$135.90m
TSROTESARO, Inc.
0.00%153.1914.7%$110.52m
BMRNBioMarin Pharmaceutical Inc.
0.00%87.334.4%$104.59m
KITEKite Pharma, Inc.
0.00%74.9116.1%$102.44m

Company Profile

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.